Billings Clinic
Especially For:

Clinical Trials

Title   Unterine Corpus Cancer: Stage 1-3
Description   CTSU GOG 0238 A Randomized Trial of Pelvic Irradiation with or Without Concurrent Weekly Cisplatin in Patients with Pelvic-Only Recurrence of Carcinoma of the Uterine Corpus
IRB Number   GOG 0238
Category   Gynencology
Inclusion/Notes   All patients must have undergone TAHwBSO at the time of the original therapy for their uterine carcinoma. Must have endometrioid adenocarcinoma w squamous differentiation, mucinous adenocarcinoma, squamous cell carcinoma, mixed carcinoma, undifferentiated carcinoma, clear cell adenocarcinoma, and serous adenocarcinoma histologies. histologically confirmed diagnosis of recurrent
endometrial cancer confined to the pelvis and/or vagina and no evidence of
extrapelvic disease. ,
Status   active
Start Date   02/11/2011
Principal Investigator (PI)   Randall Gibb, MD
Physician Profile   GYN Oncologist
Contact Name   Judy Miller, RN
Contact Email   jmiller4@billingsclinic.org
Phone   (406) 435-7482
Funding Source   NCI
Print This Page
Email to a Friend
Home | Contact | Site Map | Site Privacy Policy | Terms & Conditions | Patient Privacy Policy | Medical Records | Fast Command
2800 10th Ave. North | P.O. Box 37000 | Billings, Montana 59107 | 406.238.2500
© Copyright 2014 Billings Clinic. All Rights Reserved.